Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis
Yibo Fan, Xiaofang Che, Jinglei Qu, et al.
Annals of Surgical Oncology (2019) Vol. 26, Iss. 11, pp. 3745-3755
Closed Access | Times Cited: 157

Showing 1-25 of 157 citing articles:

The importance of exosomal PDL1 in tumour immune evasion
Dhouha Daassi, Kathleen M. Mahoney, Gordon J. Freeman
Nature reviews. Immunology (2020) Vol. 20, Iss. 4, pp. 209-215
Closed Access | Times Cited: 483
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi, Jung-Mao Hsu, Wenhao Yang, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 5, pp. 287-305
Closed Access | Times Cited: 328
Extracellular vesicles as tools and targets in therapy for diseases
Mudasir A. Kumar, Sadaf Khursheed Baba, Hana Q. Sadida, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 272
Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
Guangpeng He, Xueqiang Peng, Shibo Wei, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 120
Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
Zi Yin, Min Yu, Tingting Ma, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001698-e001698
Open Access | Times Cited: 109
Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy
Jiakang Jin, Pengcheng Yuan, Wei Yu, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 10327-10340
Closed Access | Times Cited: 100
ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression
Wei Zhang, Wenqun Zhong, Beike Wang, et al.
Developmental Cell (2022) Vol. 57, Iss. 3, pp. 329-343.e7
Open Access | Times Cited: 90
The B7:CD28 family and friends: Unraveling coinhibitory interactions
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 30
Tumor immune escape: extracellular vesicles roles and therapeutics application
Mahdi Ahmadi, Reza Abbasi, Jafar Rezaie
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
The role and application of small extracellular vesicles in gastric cancer
Hao Wu, Mengdi Fu, Jin Liu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 82
Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies
Kaijian Zhou, Shu Guo, Fei Li, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 76
Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer
Yoshihisa Shimada, Jun Matsubayashi, Yujin Kudo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 74
Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1
Chan‐Hyeong Lee, Ju‐Hyun Bae, Eunji Choe, et al.
Theranostics (2022) Vol. 12, Iss. 5, pp. 1971-1987
Open Access | Times Cited: 67
Extracellular and nuclear PD-L1 in modulating cancer immunotherapy
Wenjun Xiong, Yang Gao, Wenyi Wei, et al.
Trends in cancer (2021) Vol. 7, Iss. 9, pp. 837-846
Closed Access | Times Cited: 65
Liquid biopsy in gastric cancer: predictive and prognostic biomarkers
Zihao Zhang, Hao Wu, Wei Chong, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 64
The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation
Zhiwei Fan, Changyue Wu, Miaomiao Chen, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1041-1053
Open Access | Times Cited: 62
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Mojun Zhu, Chunhua Chen, Nathan R. Foster, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 14, pp. 3021-3031
Open Access | Times Cited: 51
Nasopharyngeal cancer cell‐derived exosomal PD‐L1 inhibits CD8+ T‐cell activity and promotes immune escape
Jie Yang, Jierong Chen, Hu Liang, et al.
Cancer Science (2022) Vol. 113, Iss. 9, pp. 3044-3054
Open Access | Times Cited: 39
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
Karama Asleh, Valerie Dery, Cathy Taylor, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Comparison of immunotherapy mediated by apoptotic bodies, microvesicles and exosomes: apoptotic bodies’ unique anti-inflammatory potential
Jing Wen, Dale Creaven, Xiangshu Luan, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors
Wenqun Zhong, Zebin Xiao, Zhiyuan Qin, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2790-2806
Open Access | Times Cited: 27
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity
Wenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113224-113224
Open Access | Times Cited: 26
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Kabsoo Shin, Joori Kim, Se Jun Park, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Tumor-derived nanoseeds condition the soil for metastatic organotropism
Mengying Hu, Candia M. Kenific, Nancy Boudreau, et al.
Seminars in Cancer Biology (2023) Vol. 93, pp. 70-82
Closed Access | Times Cited: 22
Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer
Yunjiao Wu, Huichao Fu, Jingwei Hao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top